PRFX News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

PR

Volume

6.85K

Loading chart

PR

PRFXPRF Technologies Ltd. Ordinary Shares

PRFX

Pay with—

Available Balance0.00

PR

Mkt Cap

$3.0M

Volume

6.85K

Next Earnings

N/A

Chart Financials Earnings News About Insider Filings

PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical TrialPRF Technologies announced FDA clearance of its Investigational New Drug (IND) application for OcuRing™-K, a bio-erodible intraocular ring designed to deliver ketorolac for post-cataract surgery pain and inflammation. The company plans to initiate a Phase II clinical trial in the United States with patient enrollment expected in the second half of 2026. OcuRing™-K aims to eliminate the need for complex post-surgical eye-drop regimens by providing sustained, localized drug release through a single intraoperative application.GlobeNewswire Inc. · Apr 28, 2026

What's Going On With Pharma Company PRF Technologies On Tuesday?PRF Technologies (NASDAQ: PRFX) shares tumbled on Tuesday as the broader market traded lower and investors digested the company's year-end business update. The stock, down 76.25% over the past 12 months, continues to face headwinds despite the company's strategic repositioning into a diversified platform spanning specialty pharmaceuticals and AI-driven solar analytics. Key 2025 initiatives included a majority investment in LayerBio for ocular drug delivery and the acquisition of DeepSolar for solar analytics, but traders remain skeptical of converting these initiatives into sustainable revenue.Benzinga · Apr 7, 2026

PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A MarketPainReform's DeepSolar business unit launched Smart TDD, an advanced solar Technical Due Diligence service designed to provide faster and more comprehensive assessments of solar asset performance. The service targets the $60+ billion annual solar asset M&A market by offering complete data coverage, AI-driven diagnostics, and rapid turnaround to support investors, operators, insurers, and lenders across the solar asset lifecycle.GlobeNewswire Inc. · Jan 5, 2026

BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability WeekBladeRanger (TASE: BLRN), a drone-based inspection and AI analytics provider for green energy infrastructure, will showcase its Solar Drone and DeepSolar platforms at Abu Dhabi Sustainability Week. The company is expanding its regional presence in the UAE, where $600 billion is being invested in hyperscale data centers and renewable energy systems. BladeRanger has held strategic meetings with major regional energy organizations including ADNOC, TAQA, and Masdar.Benzinga · Dec 30, 2025

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery SystemPainReform Ltd. has acquired a majority equity stake in LayerBio, a biotechnology company developing a breakthrough non-opiate, non-steroidal drug delivery system for postoperative pain management in cataract surgery, targeting the $9B global market.Benzinga · Aug 13, 2025

Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software SalesBlade Ranger Ltd. announced the achievement of a first milestone in the transaction involving the sale of its DeepSolar operations to PainReform. As a result of increased software sales by PainReform, Blade Ranger has received additional warrants worth approximately $2 million, significantly improving its financial flexibility.Benzinga · May 27, 2025

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization MarketPainReform Ltd. has acquired DeepSolar, a provider of AI-driven software solutions to optimize solar energy usage. This strategic expansion marks PainReform's entry into the rapidly growing Smart Energy Management sector, leveraging DeepSolar's technology to address the growing solar optimization market.Benzinga · Apr 10, 2025

PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar AnalyticsPainReform, a pharmaceutical company, has acquired DeepSolar, an AI-driven solar analytics platform, to expand into the clean energy sector and leverage DeepSolar's technology to optimize solar energy asset management.GlobeNewswire Inc. · Mar 5, 2025

PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion OpportunityPainReform, a pharmaceutical company, has executed a definitive agreement to acquire DeepSolar, an AI-driven solar analytics platform. This strategic acquisition is expected to expand PainReform's business while it remains committed to advancing its drug delivery technologies.Benzinga · Feb 18, 2025

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity RequirementPainReform Ltd. (Nasdaq: PRFX) received a notification from Nasdaq that it no longer meets the minimum $2.5 million stockholders' equity requirement for continued listing. The company has 45 days to submit a plan to regain compliance or an alternative continued listing standard.GlobeNewswire Inc. · Nov 7, 2024

to start trading

PR

PRFXPRF Technologies Ltd. Ordinary Shares

PRFX

Pay with—

Available Balance0.00

Your PositionYou don't own any PRFX yet.

Related Tickers

Earnings